Indraprastha Medical Past Earnings Performance
Past criteria checks 6/6
Indraprastha Medical has been growing earnings at an average annual rate of 35.8%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 11.3% per year. Indraprastha Medical's return on equity is 25.9%, and it has net margins of 10%.
Key information
35.8%
Earnings growth rate
35.9%
EPS growth rate
Healthcare Industry Growth | 29.4% |
Revenue growth rate | 11.3% |
Return on equity | 25.9% |
Net Margin | 10.0% |
Next Earnings Update | 05 Aug 2024 |
Recent past performance updates
Recent updates
Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital
Jun 12Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention
Nov 03We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00
Sep 10Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year
Aug 08Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
Jul 31Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Jan 21We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve
Nov 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Nov 02Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
May 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Jun 10Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year
Feb 21Revenue & Expenses Breakdown
How Indraprastha Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 12,447 | 1,240 | 0 | 0 |
31 Dec 23 | 12,040 | 1,126 | 912 | 0 |
30 Sep 23 | 11,745 | 1,041 | 912 | 0 |
30 Jun 23 | 11,419 | 964 | 0 | 0 |
31 Mar 23 | 10,987 | 862 | 912 | 0 |
31 Dec 22 | 10,411 | 815 | 552 | 0 |
30 Sep 22 | 10,000 | 765 | 552 | 0 |
30 Jun 22 | 9,486 | 635 | 0 | 0 |
31 Mar 22 | 8,882 | 586 | 552 | 0 |
31 Dec 21 | 8,705 | 585 | 284 | 0 |
30 Sep 21 | 8,139 | 546 | 284 | 0 |
30 Jun 21 | 7,221 | 430 | 0 | 0 |
31 Mar 21 | 6,134 | 23 | 285 | 0 |
31 Dec 20 | 6,158 | -63 | 510 | 0 |
30 Sep 20 | 6,462 | -76 | 510 | 0 |
30 Jun 20 | 7,213 | 99 | 510 | 0 |
31 Mar 20 | 8,308 | 436 | 510 | 0 |
31 Dec 19 | 8,307 | 443 | 483 | 0 |
30 Sep 19 | 8,185 | 407 | 483 | 0 |
30 Jun 19 | 8,025 | 305 | 0 | 0 |
31 Mar 19 | 7,882 | 284 | 483 | 0 |
31 Dec 18 | 7,734 | 269 | 437 | 0 |
30 Sep 18 | 7,610 | 253 | 437 | 0 |
30 Jun 18 | 7,527 | 228 | 0 | 0 |
31 Mar 18 | 7,527 | 211 | 437 | 0 |
31 Dec 17 | 7,471 | 202 | 448 | 0 |
30 Sep 17 | 7,537 | 207 | 448 | 0 |
30 Jun 17 | 7,564 | 228 | 0 | 0 |
31 Mar 17 | 7,657 | 262 | 437 | 0 |
31 Dec 16 | 7,660 | 304 | 437 | 0 |
30 Sep 16 | 7,635 | 283 | 437 | 0 |
30 Jun 16 | 7,640 | 296 | 437 | 0 |
31 Mar 16 | 7,554 | 244 | 428 | 0 |
31 Dec 15 | 7,472 | 303 | 937 | 0 |
30 Sep 15 | 7,340 | 323 | 937 | 0 |
30 Jun 15 | 7,226 | 321 | 0 | 0 |
31 Mar 15 | 7,145 | 325 | 412 | 0 |
31 Dec 14 | 7,016 | 321 | 784 | 0 |
30 Sep 14 | 6,949 | 331 | 784 | 0 |
30 Jun 14 | 6,897 | 342 | 0 | 0 |
31 Mar 14 | 6,776 | 354 | 805 | 0 |
31 Dec 13 | 6,663 | 347 | 660 | 0 |
30 Sep 13 | 6,490 | 334 | 660 | 0 |
Quality Earnings: INDRAMEDCO has high quality earnings.
Growing Profit Margin: INDRAMEDCO's current net profit margins (10%) are higher than last year (7.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INDRAMEDCO's earnings have grown significantly by 35.8% per year over the past 5 years.
Accelerating Growth: INDRAMEDCO's earnings growth over the past year (43.9%) exceeds its 5-year average (35.8% per year).
Earnings vs Industry: INDRAMEDCO earnings growth over the past year (43.9%) exceeded the Healthcare industry 26.4%.
Return on Equity
High ROE: INDRAMEDCO's Return on Equity (25.9%) is considered high.